FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 90 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,898 | -69.0% | 790 | -52.8% | 0.00% | – |
Q1 2024 | $15,793 | +196.1% | 1,673 | +111.8% | 0.00% | – |
Q4 2023 | $5,333 | +52.0% | 790 | 0.0% | 0.00% | – |
Q3 2023 | $3,508 | +34.6% | 790 | 0.0% | 0.00% | – |
Q2 2023 | $2,607 | +15.8% | 790 | 0.0% | 0.00% | – |
Q1 2023 | $2,252 | – | 790 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $70,091,000 | 17.54% |
TRV GP IV, LLC | 2,343,154 | $41,450,000 | 11.92% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $3,538,000 | 1.49% |
HighVista Strategies LLC | 89,963 | $1,591,000 | 1.27% |
Logos Global Management LP | 685,000 | $12,118,000 | 1.25% |
Monashee Investment Management LLC | 273,045 | $4,830,000 | 1.19% |
RTW INVESTMENTS, LP | 3,866,872 | $68,405,000 | 1.00% |
Parkman Healthcare Partners LLC | 250,106 | $4,424,000 | 0.98% |
Deep Track Capital, LP | 750,000 | $13,268,000 | 0.94% |
Darwin Global Management, Ltd. | 317,428 | $5,615,000 | 0.86% |